From: Abstracts of the ICARE 2023 77th SIAARTI National Congress
Sex | Male |
Age (years) | 75 |
Height (cm) | 176 |
Weight (kg) | 82 |
BMI | 26.47 |
Allergies | None |
Smoking habit | 20 cigarettes/day for 60 years |
Alcohol consumption | 2 to 3 doses daily, strongly reduced in preoperative period (6 months) |
Pathologies | Arterial Hypertension, Dyslipidemia, COPD Gold 1, Low back pain, minimal mitral and tricuspidal rigurgitation, carotid stenosis (50% R, 30% L), mixed anxiety- depressive disorder, irritable bowel syndrome,bladder Cancer stadium T1N0M0 Hg |
Previous operations: | Videolaparoscopic Cholecistectomy, appendicectomy, Epigastric Hernia Repair, endovascular prosthesis for subclavian steal syndrome, in situ melanoma exeresis, |
Home therapy | Clopidogrel, Perindopril , Indapamide, Symvastatin, venlafaxine and pantoprazol |
APACHE II score | 10 at first ICU admission |
16 at second ICU admission | |
23 after esplorative laparotomy | |
SAPS II score | 22 at first ICU admission |
30 at second ICU admission | |
75 after esplorative laparotomy | |
Charlson Comorbility Index | 6 |
Propofol infusion time (hours) | ~ 7 |
Propofol total infused dose (mg) | ~ 3300 |
Drugs administered intraoperatively | Propofol, Remifentanil, Ketamine, Rocuronium, Midazolam, Cefazolin Dexamethasone, Pantoprazole, Ketorolac, Paracetamol, Sugammadex, MgSO4, Ropivacaine |